Endo International plc (ENDP) financial statements (2020 and earlier)
Company profile
| Business Address |
MINERVA HOUSE, SIMMONSCOURT ROAD DUBLIN 4, 00000 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 1,526 | 1,149 | 987 | 517 | 272 | 410 | ||
| Cash and cash equivalents | 1,526 | 1,149 | 987 | 517 | 272 | 409 | ||
| Short-term investments | 0 | 1 | ||||||
| Restricted cash and investments | 222 | 305 | 320 | 282 | 585 | 531 | ||
| Receivables | 457 | 510 | 529 | 1,040 | 1,731 | 1,287 | ||
| Inventory, net of allowances, customer advances and progress billings | 339 | 322 | 391 | 556 | 745 | 472 | ||
| Inventory | 339 | 322 | 391 | 556 | 745 | 472 | ||
| Contract with customer, asset | 4 | 9 | ✕ | ✕ | ✕ | ✕ | ||
| Disposal group, including discontinued operation | 117 | 88 | ||||||
| Other undisclosed current assets | 101 | 47 | 43 | 78 | 54 | 608 | ||
| Total current assets: | 2,649 | 2,343 | 2,271 | 2,589 | 3,475 | 3,307 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 54 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 501 | 499 | 524 | 670 | 671 | 429 | ||
| Long-term investments and receivables | 1 | 1 | 2 | 4 | 2 | |||
| Long-term investments | 1 | 1 | 2 | 4 | 2 | |||
| Intangible assets, net (including goodwill) | 6,554 | 7,222 | 8,768 | 10,589 | 15,112 | 6,957 | ||
| Goodwill | 3,615 | 3,765 | 4,450 | 4,729 | 7,299 | 3,763 | ||
| Intangible assets, net (excluding goodwill) | 2,938 | 3,457 | 4,318 | 5,859 | 7,813 | 3,194 | ||
| Other noncurrent assets | 77 | 67 | 60 | 417 | 80 | 210 | ||
| Deferred tax assets, net | ✕ | 9 | 5 | |||||
| Other undisclosed noncurrent assets | 1 | 12 | 8 | |||||
| Total noncurrent assets: | 7,186 | 7,789 | 9,365 | 11,686 | 15,875 | 7,602 | ||
| TOTAL ASSETS: | 9,835 | 10,132 | 11,636 | 14,275 | 19,350 | 10,910 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 937 | 1,009 | 1,097 | 1,454 | 1,504 | 1,500 | ||
| Accounts payable | 110 | 96 | 344 | 308 | ||||
| Accrued liabilities | 172 | 150 | 1,097 | 1,454 | 1,151 | 1,192 | ||
| Employee-related liabilities | 72 | 90 | ||||||
| Taxes payable | 11 | 2 | 2 | 9 | 9 | |||
| Interest and dividends payable | 101 | 130 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 471 | 542 | (2) | (9) | ||||
| Deferred revenue | 2 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 50 | 40 | 41 | 140 | 339 | 162 | ||
| Business combination, contingent consideration, liability | 71 | 109 | ||||||
| Deferred tax liabilities | ✕ | 0 | ||||||
| Contract with customer, liability | ✕ | 2 | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | 678 | 899 | 1,013 | 932 | 1,632 | 1,437 | ||
| Total current liabilities: | 1,668 | 1,950 | 2,221 | 2,635 | 3,474 | 3,099 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 8,416 | 8,258 | 8,279 | 8,190 | 8,305 | 4,261 | ||
| Long-term debt, excluding current maturities | 8,365 | 8,224 | 8,242 | 8,141 | 8,252 | 4,202 | ||
| Capital lease obligations | ✕ | 34 | 37 | 48 | 53 | 59 | ||
| Operating lease, liability | 51 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 404 | 422 | 434 | 605 | 1,107 | 937 | ||
| Deferred tax liabilities, net | ✕ | 871 | 724 | |||||
| Deferred income tax liabilities | 32 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other liabilities | 372 | 422 | 434 | 605 | 236 | 213 | ||
| Other undisclosed noncurrent liabilities | 0 | 217 | 144 | 496 | 204 | |||
| Total noncurrent liabilities: | 8,820 | 8,681 | 8,930 | 8,939 | 9,908 | 5,402 | ||
| Total liabilities: | 10,487 | 10,631 | 11,151 | 11,574 | 13,382 | 8,501 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent | (661) | (498) | 485 | 2,702 | 5,968 | 2,375 | ||
| Preferred stock | 0 | 0 | 0 | |||||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 8,895 | 8,856 | 8,791 | 8,743 | 8,693 | 3,094 | ||
| Accumulated other comprehensive loss | (223) | (229) | (210) | (353) | (384) | (124) | ||
| Accumulated deficit | (9,334) | (9,125) | (8,097) | (5,688) | (2,341) | (595) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | |||||||
| Stockholders' equity attributable to noncontrolling interest | (0) | 33 | ||||||
| Other undisclosed stockholders' equity | 0 | 0 | ||||||
| Total stockholders' equity: | (661) | (498) | 485 | 2,702 | 5,968 | 2,408 | ||
| Other undisclosed liabilities and equity | 9 | |||||||
| TOTAL LIABILITIES AND EQUITY: | 9,835 | 10,132 | 11,636 | 14,275 | 19,350 | 10,910 | ||
Income statement (P&L) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 2,936 | 2,947 | 3,469 | 4,010 | 3,269 | 2,877 | |
| Revenue, net | ✕ | ✕ | 2,323 | ||||
| Cost of revenue | (1,602) | (1,632) | (2,229) | (2,635) | (2,076) | (1,401) | |
| Cost of goods and services sold | (129) | (41) | (1,231) | ||||
| Gross profit: | 1,333 | 1,315 | 1,240 | 1,375 | 1,193 | 1,477 | |
| Operating expenses | (1,299) | (1,785) | (2,200) | (4,847) | (2,089) | (1,402) | |
| Other undisclosed operating loss | (37) | (972) | |||||
| Operating income (loss): | 34 | (469) | (960) | (3,472) | (933) | (897) | |
| Nonoperating income (expense) | (2) | 52 | 17 | 0 | (64) | 43 | |
| Foreign currency transaction gain (loss), before tax | (1) | 4 | 8 | ||||
| Other nonoperating income (expense) | (16) | 6 | 17 | 0 | (64) | 30 | |
| Interest and debt expense | 119 | (52) | |||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (136) | (522) | (488) | (453) | (441) | (272) | |
| Income (loss) from continuing operations before equity method investments, income taxes: | 16 | (939) | (1,483) | (3,924) | (1,438) | (1,126) | |
| Income from equity method investments | 8 | ||||||
| Other undisclosed loss from continuing operations before income taxes | (404) | ||||||
| Loss from continuing operations before income taxes: | (388) | (939) | (1,483) | (3,924) | (1,438) | (1,117) | |
| Income tax expense (benefit) | (30) | (23) | 250 | 700 | 1,137 | 402 | |
| Other undisclosed loss from continuing operations | (8) | ||||||
| Loss from continuing operations: | (418) | (962) | (1,233) | (3,224) | (300) | (724) | |
| Income (loss) from discontinued operations | (26) | (70) | (803) | (123) | (1,195) | 6 | |
| Net loss: | (444) | (1,031) | (2,035) | (3,347) | (1,495) | (718) | |
| Net income (loss) attributable to noncontrolling interest | (0) | 0 | (3) | ||||
| Other undisclosed net loss attributable to parent | (52) | ||||||
| Net loss available to common stockholders, diluted: | (496) | (1,031) | (2,035) | (3,347) | (1,495) | (721) | |
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (444) | (1,031) | (2,035) | (3,347) | (1,495) | (718) | |
| Other comprehensive income (loss) | (12) | (19) | 144 | 31 | (257) | (122) | |
| Comprehensive loss: | (456) | (1,051) | (1,892) | (3,316) | (1,752) | (841) | |
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (0) | 0 | 3 | ||||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (45) | (0) | 0 | (3) | |||
| Comprehensive loss, net of tax, attributable to parent: | (502) | (1,051) | (1,892) | (3,316) | (1,751) | (840) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.